Newly updated guidelines from the American Society for Radiation Oncology (ASTRO) capture the World Health Organization (WHO)’s 2021 reclassification of glioblastoma as grade 4 adult-type diffuse ...
Low-grade brain tumors known as IDH-mutant gliomas CNS WHO grade 2 are life-threatening in spite of their slow growth.
ARLINGTON, Va., June 26, 2025 — A new clinical guideline from the American Society for Radiation Oncology (ASTRO) focuses on the use of radiation therapy to treat adult patients with World Health ...
A new drug for treatment of a type of brain cancer, called IDH-mutant low-grade glioma, was approved Aug. 6 by the U.S. Food and Drug Administration (FDA). The promising new drug stems from a 2008 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback